07-02-21 BioGaia signs agreement with Delta Medical


Press release                                                                   
21 February 2007                                                                



                   BioGaia signs agreement with Delta Medical                   


BioGaia AB has signed a distribution agreement with Delta Medical Promotions AG,
Switzerland, which gives Delta Medical exclusive rights to distribute BioGaia's 
Probiotic drops in Ukraine and non-exclusive rights in Russia. The drops will be
sold under the BioGaia brand.                                                   

Delta Medical, which is strong in paediatric medicine, will sell BioGaia        
Probiotic drops mainly through pharmacies and drugstores. The company has a     
sales force of close to 300 medical representatives that promotes the products  
directly to doctors.                                                            

”We see a great potential for our products in the highly populated countries of 
former Soviet Union such as Russia and Ukraine. With Delta Medical's expertise  
in the paediatric field, we are building a strong partnership for our most      
rapidly growing product” says Peter Rothschild.                                 

”BioGaia Probiotic Drops is a unique product that fits well with our paediatric 
portfolio” says Will Wickham, General Director, Delta Medical.                  

The registration process will begin immediately and the launch is planned before
year-end.                                                                       









Latest press releases from BioGaia:                                             
2007-02-14	BioGaia AB Year-end report 2006                                      
2007-01-16	BioGaia signs agreement with Semper                                  
2007-01-09	Lactobacillus reuteri against colic                                  




For additional information contact:                                             
Peter Rothschild, president, telephone: +46 (0)8 - 555 293 00                   
Jan Annwall, executive vice president, telephone: +46 (0)8 - 555 293 00         
--------------------------------------------------------------------------------
-----------------------------------------------------------                     
BioGaia is a biotechnology company that develops, markets and sells probiotic   
products with documented health benefits. The products are primarily based on   
the lactic acid bacterium Lactobacillus reuteri (Reuteri), which has            
health-enhancing effects. The class B share of the Parent Company BioGaia AB is 
quoted on the small cap list of the Stockholm Stock Exchange.                   

www.biogaia.com